ArticleInternational journal of cancer2025

Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies.

José A García-Saenz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.